Worldwide Shipping✦For research purposes only.✦We guarantee quality and assurance.✦Worldwide Shipping✦For research purposes only.✦We guarantee quality and assurance.✦Worldwide Shipping✦For research purposes only.✦We guarantee quality and assurance.✦
MedTruva
BODYMAP™ About Sign in
TIRZP 2GLP
TIRZP 2GLP - Image 2
TIRZP 2GLP - Image 3
TIRZP 2GLP - Image 4
TIRZP 2GLP - Image 5

TIRZP 2GLP

Price range: AED155.00 through AED860.00

Tirzepatide is a long-acting, dual GIP and GLP-1 receptor agonist supplied in 30 mg, 40 mg, and 50 mg laboratory research formats. Strictly for laboratory research and not for human or veterinary use.

Not available to order yet. Only Retatrutide 40mg is open for ordering in Dubai right now.

98.99%+ PurityResearch GradeCOA VerifiedThird-Party Tested
View the certificate of analysis for this compound →

Not available to order yet — coming soon.

American based – premium qualityTrusted brand – customers choice100% tested – premium qualityCOA certified – lab tested, always trustedBest pricing – always competitive

The Purity Guarantee

Verified ≥99% by HPLC & mass spectrometry, third-party tested, with a lot-matched Certificate of Analysis on every vial.

  • Certificate of Analysis available for every lot
  • ≥99% purity, HPLC & mass-spec verified
  • Secure checkout · Free shipping on orders AED 1,000+
SKU: MT-TIRZ Category: Tags: , , ,

Description

Scientific overview

Tirzepatide (LY3298176) is a synthetic, long-acting peptide receptor agonist engineered to activate the glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). These class B G-protein-coupled receptors participate in nutrient-responsive signaling, pancreatic hormone secretion, appetite regulation, and energy metabolism.

The molecule is based on a modified GIP sequence and incorporates a fatty di-acid moiety that extends its duration of action. Tirzepatide has been studied extensively in clinical research and is the active ingredient in approved prescription products. The 30 mg, 40 mg, and 50 mg catalog options offered here are laboratory research formats—not approved clinical dosage strengths or directions for use.

Research characteristics

  • Molecular class: synthetic, long-acting peptide receptor agonist
  • Primary targets: GIPR and GLP-1R
  • Research focus: incretin signaling, glucose and lipid metabolism, appetite signaling, and energy homeostasis
  • Available research formats: 30 mg, 40 mg, and 50 mg

Research-use notice: Supplied for laboratory research only. Not for human or veterinary use, diagnosis, treatment, or consumption. These catalog vial sizes must not be interpreted as clinical dosing. No medical or therapeutic claims are made.

Certificate of Analysis

Every Medtruva lot ships with an independent, third-party certificate of analysis covering identity and purity. The certificate for each lot is published here and searchable by lot number.

Sample · Lab verification in progress
CompoundTIRZP 2GLP · MT-TIRZ
Lot numberAssigned at first production run
Analytical methodsRP-HPLC (purity) · LC-MS (identity)
PurityPending lab verification
Testing laboratoryIndependent third-party laboratory
Report datePending

Sample certificate. Laboratory testing for the launch lots is in progress. The document below is a sample showing the format every Medtruva certificate follows; it will be replaced by the signed lab report for this lot before ordering opens.

View sample certificate (PDF) Look up a lot number →

For laboratory research only. Certificates describe the analytical results of a specific lot and are not a statement of suitability for any use.

Additional information

Vial Size

30 mg, 40 mg, 50 mg, 1 Year Supply of Research (3 x 40 mg), Research Sharing Package (10 x 40 mg)

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

Related products